• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CREB3L2-ATF4 异二聚体定义了与神经病理学相关的阿尔茨海默病基因表达的转录枢纽。

CREB3L2-ATF4 heterodimerization defines a transcriptional hub of Alzheimer's disease gene expression linked to neuropathology.

机构信息

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Integrated Program in Cellular, Molecular, and Biomedical Studies, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

出版信息

Sci Adv. 2023 Mar 3;9(9):eadd2671. doi: 10.1126/sciadv.add2671.

DOI:10.1126/sciadv.add2671
PMID:36867706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984184/
Abstract

Gene expression is changed by disease, but how these molecular responses arise and contribute to pathophysiology remains less understood. We discover that β-amyloid, a trigger of Alzheimer's disease (AD), promotes the formation of pathological CREB3L2-ATF4 transcription factor heterodimers in neurons. Through a multilevel approach based on AD datasets and a novel chemogenetic method that resolves the genomic binding profile of dimeric transcription factors (ChIPmera), we find that CREB3L2-ATF4 activates a transcription network that interacts with roughly half of the genes differentially expressed in AD, including subsets associated with β-amyloid and tau neuropathologies. CREB3L2-ATF4 activation drives tau hyperphosphorylation and secretion in neurons, in addition to misregulating the retromer, an endosomal complex linked to AD pathogenesis. We further provide evidence for increased heterodimer signaling in AD brain and identify dovitinib as a candidate molecule for normalizing β-amyloid-mediated transcriptional responses. The findings overall reveal differential transcription factor dimerization as a mechanism linking disease stimuli to the development of pathogenic cellular states.

摘要

基因表达会受到疾病的影响,但这些分子反应是如何产生的,以及它们如何导致病理生理学变化,目前人们对此了解较少。我们发现β-淀粉样蛋白(一种阿尔茨海默病的诱因)会促进神经元中病理性 CREB3L2-ATF4 转录因子异二聚体的形成。通过基于 AD 数据集的多层次方法和一种新的化学遗传学方法(ChIPmera,可解析二聚体转录因子的基因组结合图谱),我们发现 CREB3L2-ATF4 会激活一个转录网络,该网络与 AD 中差异表达的大约一半基因相互作用,包括与β-淀粉样蛋白和 tau 神经病理学相关的亚群。CREB3L2-ATF4 的激活会导致神经元中的 tau 过度磷酸化和分泌,此外还会导致逆向转运体(与 AD 发病机制相关的内体复合物)失调。我们进一步提供了 AD 大脑中异二聚体信号增加的证据,并确定多韦替尼是一种可用于调节β-淀粉样蛋白介导的转录反应的候选分子。总的来说,这些发现揭示了差异转录因子二聚化作为一种将疾病刺激与致病细胞状态的发展联系起来的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/5d65ef37a735/sciadv.add2671-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/b2e0f244f4cb/sciadv.add2671-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/aa79f0e5feea/sciadv.add2671-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/6f6f3fab0abc/sciadv.add2671-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/be98c0aafec0/sciadv.add2671-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/d4cf3cfe4fb9/sciadv.add2671-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/e2a1f2eb3bef/sciadv.add2671-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/5c1380248896/sciadv.add2671-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/5d65ef37a735/sciadv.add2671-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/b2e0f244f4cb/sciadv.add2671-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/aa79f0e5feea/sciadv.add2671-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/6f6f3fab0abc/sciadv.add2671-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/be98c0aafec0/sciadv.add2671-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/d4cf3cfe4fb9/sciadv.add2671-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/e2a1f2eb3bef/sciadv.add2671-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/5c1380248896/sciadv.add2671-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789c/9984184/5d65ef37a735/sciadv.add2671-f8.jpg

相似文献

1
CREB3L2-ATF4 heterodimerization defines a transcriptional hub of Alzheimer's disease gene expression linked to neuropathology.CREB3L2-ATF4 异二聚体定义了与神经病理学相关的阿尔茨海默病基因表达的转录枢纽。
Sci Adv. 2023 Mar 3;9(9):eadd2671. doi: 10.1126/sciadv.add2671.
2
ATF4: a Novel Potential Therapeutic Target for Alzheimer's Disease.激活转录因子4:阿尔茨海默病的新型潜在治疗靶点
Mol Neurobiol. 2015 Dec;52(3):1765-1770. doi: 10.1007/s12035-014-8970-8. Epub 2014 Nov 9.
3
Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ.激活转录因子 4(ATF4)通过与转录调节剂 C/EBPβ 形成异二聚体促进骨骼肌萎缩。
J Biol Chem. 2020 Feb 28;295(9):2787-2803. doi: 10.1074/jbc.RA119.012095. Epub 2020 Jan 17.
4
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
5
Integration of CREB and bHLH transcriptional signaling pathways through direct heterodimerization of the proteins: role in muscle and testis development.通过蛋白质直接异源二聚化整合CREB和bHLH转录信号通路:在肌肉和睾丸发育中的作用
Mol Reprod Dev. 2008 Nov;75(11):1637-52. doi: 10.1002/mrd.20902.
6
Crystal structure of the CCAAT box/enhancer-binding protein beta activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA.无DNA情况下CCAAT盒/增强子结合蛋白β激活转录因子-4碱性亮氨酸拉链异二聚体的晶体结构
J Biol Chem. 2001 Jan 5;276(1):505-13. doi: 10.1074/jbc.M005594200.
7
Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions.轴突合成的激活转录因子4在脑区之间传递神经退行性信号。
Cell. 2014 Aug 28;158(5):1159-1172. doi: 10.1016/j.cell.2014.07.001.
8
ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.激活转录因子4(ATF4)通过C/EBPε和C/EBPα对髓系特异性基因的转录激活进行差异调节。
J Leukoc Biol. 2007 Jun;81(6):1535-47. doi: 10.1189/jlb.0806516. Epub 2007 Mar 8.
9
Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease.删除 eIF2α 激酶 GCN2 不能挽救与阿尔茨海默病相关的记忆衰退。
PLoS One. 2013 Oct 11;8(10):e77335. doi: 10.1371/journal.pone.0077335. eCollection 2013.
10
Quercetin reduces eIF2α phosphorylation by GADD34 induction.槲皮素通过诱导GADD34降低eIF2α磷酸化水平。
Neurobiol Aging. 2015 Sep;36(9):2509-18. doi: 10.1016/j.neurobiolaging.2015.05.006. Epub 2015 May 15.

引用本文的文献

1
The Progress of Cognitive Dysfunction Impairment Caused by Temporal Lobe Epilepsy.颞叶癫痫所致认知功能障碍的研究进展
J Mol Neurosci. 2025 Jun 21;75(3):81. doi: 10.1007/s12031-025-02365-0.
2
Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer's disease pathology.通过蛋白酶体抑制和血红素调节激酶1激活对阿尔茨海默病病理中CREB3L2-ATF4异二聚化的调控
Cell Death Dis. 2025 Mar 31;16(1):225. doi: 10.1038/s41419-025-07586-0.
3
The broken Alzheimer's disease genome.破碎的阿尔茨海默病基因组。

本文引用的文献

1
Drugging Fuzzy Complexes in Transcription.转录过程中对模糊复合物的药物作用
Front Mol Biosci. 2021 Dec 21;8:795743. doi: 10.3389/fmolb.2021.795743. eCollection 2021.
2
Alzheimer's vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling.阿尔茨海默病易感脑区依赖于独特的内体再循环所需的逆行转运核心。
Cell Rep. 2021 Dec 28;37(13):110182. doi: 10.1016/j.celrep.2021.110182.
3
Aducanumab and the "post-amyloid" era of Alzheimer research?阿杜卡努单抗与阿尔茨海默病研究的“淀粉样蛋白后”时代?
Cell Genom. 2024 May 8;4(5):100555. doi: 10.1016/j.xgen.2024.100555. Epub 2024 May 1.
4
Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.西地那非治疗阿尔茨海默病的候选药物:来自患者诱导多能干细胞衍生神经元的真实世界患者数据观察和机制观察。
J Alzheimers Dis. 2024;98(2):643-657. doi: 10.3233/JAD-231391.
5
ATF4 in cellular stress, ferroptosis, and cancer.细胞应激、铁死亡和癌症中的激活转录因子4(ATF4)
Arch Toxicol. 2024 Apr;98(4):1025-1041. doi: 10.1007/s00204-024-03681-x. Epub 2024 Feb 21.
Neuron. 2021 Oct 6;109(19):3045-3047. doi: 10.1016/j.neuron.2021.09.007. Epub 2021 Sep 27.
4
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model.细胞外伴侣蛋白簇集素增强了细胞模型中 Tau 聚集物的种子形成。
Nat Commun. 2021 Aug 11;12(1):4863. doi: 10.1038/s41467-021-25060-1.
5
Machine learning identifies candidates for drug repurposing in Alzheimer's disease.机器学习确定阿尔茨海默病药物再利用的候选者。
Nat Commun. 2021 Feb 15;12(1):1033. doi: 10.1038/s41467-021-21330-0.
6
An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease.一种综合的多组学方法确定了与阿尔茨海默病相关的表观遗传改变。
Nat Genet. 2020 Oct;52(10):1024-1035. doi: 10.1038/s41588-020-0696-0. Epub 2020 Sep 28.
7
mRNAs, proteins and the emerging principles of gene expression control.mRNA、蛋白质和基因表达控制的新兴原则。
Nat Rev Genet. 2020 Oct;21(10):630-644. doi: 10.1038/s41576-020-0258-4. Epub 2020 Jul 24.
8
Mechanisms, regulation and functions of the unfolded protein response.未折叠蛋白反应的机制、调控和功能。
Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438. doi: 10.1038/s41580-020-0250-z. Epub 2020 May 26.
9
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.阿尔茨海默病全基因组关联研究风险基因座的解读。
Lancet Neurol. 2020 Apr;19(4):326-335. doi: 10.1016/S1474-4422(19)30435-1. Epub 2020 Jan 24.
10
Promotion of Axon Growth by the Secreted End of a Transcription Factor.翻译:转录因子分泌端促进轴突生长。
Cell Rep. 2019 Oct 8;29(2):363-377.e5. doi: 10.1016/j.celrep.2019.08.101.